CVS Health Corporation
CVS
$76.19
$2.012.71%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.77B | 469.00M | 4.53B | 5.28B | 4.61B |
| Total Depreciation and Amortization | 4.61B | 4.61B | 4.63B | 4.61B | 4.60B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.74B | 4.88B | 59.00M | 52.00M | -213.00M |
| Change in Net Operating Assets | -1.47B | -847.00M | -1.66B | -1.19B | 109.00M |
| Cash from Operations | 10.64B | 9.11B | 7.57B | 8.76B | 9.11B |
| Capital Expenditure | -2.83B | -2.82B | -2.79B | -2.82B | -2.78B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -436.00M | -439.00M | -161.00M | -90.00M | -95.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.60B | -1.17B | -2.73B | -3.37B | -4.74B |
| Cash from Investing | -5.87B | -4.42B | -5.68B | -6.28B | -7.61B |
| Total Debt Issued | 3.97B | 8.24B | 5.79B | 7.31B | 9.83B |
| Total Debt Repaid | -5.75B | -7.55B | -5.30B | -6.36B | -4.77B |
| Issuance of Common Stock | 394.00M | 327.00M | 324.00M | 302.00M | 361.00M |
| Repurchase of Common Stock | -158.00M | -149.00M | -133.00M | -161.00M | -3.21B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.40B | -3.39B | -3.38B | -3.37B | -3.37B |
| Other Financing Activities | 0.00 | 41.00M | 11.00M | 36.00M | 26.00M |
| Cash from Financing | -4.94B | -2.48B | -2.68B | -2.24B | -1.14B |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -172.00M | 2.21B | -795.00M | 239.00M | 359.00M |